WJ13404

· Suzhou Junjing BioSciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WJ13404, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing